Exhibitors Search
GENIXCURE Inc.
Booth no.
H60
| Exhibition | PARTNERING |
|---|---|
| Country | Korea, South |
| Address | 77 Changnyong-daero 256beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea |
| Tel (Rep.) | 031-213-5115 |
| Website | http://www.genix-cure.com |
Company Introduction
GENIXCURE Inc. is building its future growth on next-generation AAV vector platforms, aiming to secure global competitiveness through the integration of AI-driven, innovative vector development.
Our proprietary CARE™ platform, powered by InsightMiner™, is a core technology designed to overcome the limitations of conventional AAV in terms of cell tropism, safety, and productivity. This breakthrough opens new possibilities for developing gene therapies targeting neurodegenerative diseases.
By expanding R&D capabilities through collaboration with domestic and global partners, we strive to deliver safe and effective therapeutic options to patients.
At GENIXCURE, our top priority is to bring new hope to patients suffering from intractable diseases.
Our proprietary CARE™ platform, powered by InsightMiner™, is a core technology designed to overcome the limitations of conventional AAV in terms of cell tropism, safety, and productivity. This breakthrough opens new possibilities for developing gene therapies targeting neurodegenerative diseases.
By expanding R&D capabilities through collaboration with domestic and global partners, we strive to deliver safe and effective therapeutic options to patients.
At GENIXCURE, our top priority is to bring new hope to patients suffering from intractable diseases.
Promotional video
Exhibit Item
Next-Generation High-Efficiency AAV Vectors to Enhance Neurodegenerative Disease Therapy
Exhibit Item Images
-
Product Name : Next-Generation High-Efficiency AAV Vectors to Enhance Neurodegenerative Disease TherapyA precisely engineered next-generation AAV vector that maximizes cell specificity, expression efficiency, and productivity to overcome the limitations of neurodegenerative disease therapy development.
Exhibit Description
Through our proprietary machine learning platform InsightMiner™ powered by the CARE™ system, we develop high-efficiency next-generation AAV vectors with enhanced target specificity, immune evasion, and reduced toxicity.
Co-Exhibitor or
Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.